127 related articles for article (PubMed ID: 2757334)
1. [Curietherapy using a ruthenium and iridium disk in the treatment of choroid melanoma].
Gérard JP; Grange JD; Romestaing P; Sentenac I; De Laroche G; Montbarbon X; Mahe M; Salerno N; Baude JP; Bonnet M
Ann Radiol (Paris); 1989; 32(2):107-11. PubMed ID: 2757334
[TBL] [Abstract][Full Text] [Related]
2. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
3. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.
Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):392-400. PubMed ID: 15990248
[TBL] [Abstract][Full Text] [Related]
4. Local tumor control after 106Ru brachytherapy of choroidal melanoma.
Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):385-91. PubMed ID: 15913907
[TBL] [Abstract][Full Text] [Related]
5. [Retrospective analysis of ruthenium-106 brachytherapy for small and medium-sized malignant melanoma of the posterior choroid].
Stoffelns BM; Kutzner J; Jochem T
Klin Monbl Augenheilkd; 2002 Apr; 219(4):216-20. PubMed ID: 12022004
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of choroid melanoma with contact curietherapy using ruthenium 106].
Muller RP; Busse H; Kroll P; Gast E
J Fr Ophtalmol; 1985; 8(10):639-43. PubMed ID: 3833880
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of 100 melanomas of the choroid and ciliary body treated by application of ruthenium (RU 106 Rh 106)].
Grange JD; Gerard JP; Ragab M; Quintero P; Delaroche G; Jean-Louis B; Sentenac I; Fontaniere B; Bievelez B
Bull Soc Ophtalmol Fr; 1989 May; 89(5):679-82. PubMed ID: 2590984
[TBL] [Abstract][Full Text] [Related]
8. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
Bacin F; Kwiatkowski F; Dalens H; Rozan R; Gagyi S; Donnarieix D; Bard JJ; Robert JL
J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of various malignant melanomas of the choroid using a combination of ruthenium 106 and cobalt 60].
Bacin F; Rozan R; Donnarieix D; Dalens H
Ophtalmologie; 1990; 4(3):225-8. PubMed ID: 2250952
[TBL] [Abstract][Full Text] [Related]
10. Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy.
Papageorgiou KI; Cohen VM; Bunce C; Kinsella M; Hungerford JL
Br J Ophthalmol; 2011 Feb; 95(2):166-70. PubMed ID: 20889528
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma.
Verschueren KM; Creutzberg CL; Schalij-Delfos NE; Ketelaars M; Klijsen FL; Haeseker BI; Ligtenberg SM; Keunen JE; Marijnen CA
Radiother Oncol; 2010 Jun; 95(3):332-8. PubMed ID: 20416963
[TBL] [Abstract][Full Text] [Related]
12. [Transpupillary thermotherapy of choroidal melanoma].
Schneider H; Fischer K; Fietkau R; Guthoff RF
Klin Monbl Augenheilkd; 1999 Feb; 214(2):90-5. PubMed ID: 10218201
[TBL] [Abstract][Full Text] [Related]
13. The comparison of ruthenium brachytherapy and simultaneous transpupillary thermotherapy of choroidal melanoma with brachytherapy alone.
Yarovoy AA; Magaramov DA; Bulgakova ES
Brachytherapy; 2012; 11(3):224-9. PubMed ID: 22104351
[TBL] [Abstract][Full Text] [Related]
14. [Choroid melanoma. A retrospective randomized comparative study of ruthenium irradiation vs enucleation].
Guthoff R; Frischmuth J; Jensen OA; Bjerrum K; Prause JU
Klin Monbl Augenheilkd; 1992 Apr; 200(4):257-61. PubMed ID: 1614086
[TBL] [Abstract][Full Text] [Related]
15. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
16. Visual outcome, local tumour control, and eye preservation after 106Ru/Rh brachytherapy for choroidal melanoma.
Isager P; Ehlers N; Urbak SF; Overgaard J
Acta Oncol; 2006; 45(3):285-93. PubMed ID: 16644571
[TBL] [Abstract][Full Text] [Related]
17. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
[TBL] [Abstract][Full Text] [Related]
18. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma.
Wilson MW; Hungerford JL
Ophthalmology; 1999 Aug; 106(8):1579-87. PubMed ID: 10442907
[TBL] [Abstract][Full Text] [Related]
19. [Radiation optic neuropathy after the brachytherapy of the uveal melanoma].
Szuścik I; Romanowska-Dixon B; Markiewicz A; Pogrzebielski A; Jakubowska B
Klin Oczna; 2006; 108(7-9):278-80. PubMed ID: 17290823
[TBL] [Abstract][Full Text] [Related]
20. Malignant melanomas of the choroid and ruthenium applicators.
Huyghe JP; Verbraeken H; Goes F; De Wilde G; Hanssens M; Brabant P; Van Hijfte R; De Laey JJ
Bull Soc Belge Ophtalmol; 1990; 238():137-43. PubMed ID: 2131116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
